Literature DB >> 5394466

[Resorption, excretion and metabolism after intravenous and oral administration of HB 419-14C in man].

W Rupp, O Christ, W Heptner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5394466

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


× No keyword cloud information.
  14 in total

Review 1.  ATP-sensitive K+ channels in the kidney.

Authors:  U Quast
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

2.  Interaction of sulphonylurea derivatives with vascular ATP-sensitive potassium channels in humans.

Authors:  P J Bijlstra; J A Lutterman; F G Russel; T Thien; P Smits
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

3.  Extrapancreatic and pancreatic actions of glibenclamide in rats.

Authors:  W Heptner; A Zermatten; H M Kellner; O Christ; J P Felber
Journal:  Diabetologia       Date:  1977-08       Impact factor: 10.122

4.  Serum glibenclamide in diabetic patients, and influence of food on the kinetics and effects of glibenclamide.

Authors:  G Sartor; A Melander; B Scherstén; E Wåhlin-Boll
Journal:  Diabetologia       Date:  1980-01       Impact factor: 10.122

5.  Behaviour of glibenclamide on repeated administration to diabetic patients.

Authors:  L Balant; G R Zahnd; F Weber; J Fabre
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

6.  Pharmacokinetics of intravenous glibenclamide investigated by a high performance liquid chromatographic assay.

Authors:  H J Rogers; R G Spector; P J Morrison; I D Bradbrook
Journal:  Diabetologia       Date:  1982-07       Impact factor: 10.122

Review 7.  Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs.

Authors:  L Balant
Journal:  Clin Pharmacokinet       Date:  1981 May-Jun       Impact factor: 6.447

8.  [Potentiation of the hypoglycemic effect of sulfonylurea derivatives by drugs. II. Pharmacokinetics and metabolism of glibenclamide (HB 419) in presence of phenylbutazone].

Authors:  E Schulz; K Koch; F H Schmidt
Journal:  Eur J Clin Pharmacol       Date:  1971-12       Impact factor: 2.953

9.  The paradoxical effect of cimetidine and ranitidine on glibenclamide pharmacokinetics and pharmacodynamics.

Authors:  R T Kubacka; E J Antal; R P Juhl
Journal:  Br J Clin Pharmacol       Date:  1987-06       Impact factor: 4.335

10.  Comparison of the pharmacokinetics of glipizide and glibenclamide in man.

Authors:  L Balant; J Fabre; G R Zahnd
Journal:  Eur J Clin Pharmacol       Date:  1975       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.